BBI
Income statement / Annual
Last year (2021), Brickell Biotech, Inc.'s total revenue was $404,000.00,
a decrease of 77.83% from the previous year.
In 2021, Brickell Biotech, Inc.'s net income was -$39.54 M.
See Brickell Biotech, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
Operating Revenue |
$404,000.00 |
$1.82 M |
$7.92 M |
$1.62 M |
$13.82 M |
$14.53 M |
$20.95 M |
$15.22 M |
$7.72 M |
$17.52 M |
Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$1.44 M
|
$6.48 M
|
$6.29 M
|
$10.93 M
|
$10.82 M
|
$12.70 M
|
$0.00
|
Gross Profit |
$404,000.00
|
$1.82 M
|
$7.92 M
|
$186,000.00
|
$7.34 M
|
$8.24 M
|
$10.02 M
|
$4.39 M
|
-$4.98 M
|
$17.52 M
|
Gross Profit Ratio |
1
|
1
|
1
|
0.11
|
0.53
|
0.57
|
0.48
|
0.29
|
-0.65
|
1
|
Research and Development Expenses |
$28.23 M
|
$11.22 M
|
$20.21 M
|
$12.33 M
|
$14.39 M
|
$10.36 M
|
$11.06 M
|
$11.47 M
|
$14.56 M
|
$17.34 M
|
General & Administrative Expenses |
$12.42 M
|
$11.58 M
|
$12.17 M
|
$8.94 M
|
$12.81 M
|
$13.35 M
|
$19.29 M
|
$20.38 M
|
$24.51 M
|
$23.61 M
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$1.44 M
|
$6.48 M
|
$6.29 M
|
$10.93 M
|
$10.82 M
|
$12.70 M
|
$13.06 M
|
Selling, General & Administrative Expenses |
$12.42 M
|
$11.58 M
|
$12.17 M
|
$10.38 M
|
$19.29 M
|
$19.64 M
|
$30.22 M
|
$31.20 M
|
$37.21 M
|
$36.67 M
|
Other Expenses |
$0.00
|
$0.00
|
$0.00
|
-$1.44 M
|
-$6.48 M
|
-$6.29 M
|
-$10.93 M
|
-$10.82 M
|
-$12.70 M
|
-$13.06 M
|
Operating Expenses |
$40.65 M
|
$22.80 M
|
$32.39 M
|
$21.27 M
|
$27.21 M
|
$23.71 M
|
$30.35 M
|
$31.84 M
|
$39.07 M
|
$40.95 M
|
Cost And Expenses |
$40.65 M
|
$22.80 M
|
$32.39 M
|
$22.70 M
|
$33.68 M
|
$30.00 M
|
$41.28 M
|
$42.67 M
|
$51.77 M
|
$40.95 M
|
Interest Income |
$0.00
|
$0.00
|
$0.00
|
$61,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Interest Expense |
$69,000.00
|
$0.00
|
$2.10 M
|
$1.09 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$22,000.00
|
$10,000.00
|
$28,000.00
|
$151,000.00
|
$793,000.00
|
$1.12 M
|
$1.16 M
|
$1.66 M
|
$2.21 M
|
$1.98 M
|
EBITDA |
-$40.24 M |
-$20.98 M |
-$24.47 M |
-$19.65 M |
-$13.39 M |
-$7.86 M |
-$8.08 M |
-$14.83 M |
-$29.03 M |
-$23.43 M |
EBITDA Ratio |
-97.48
|
-11.47
|
-2.75
|
-9.26
|
-0.88
|
-0.54
|
-0.39
|
-0.97
|
-3.76
|
-1.19
|
Operating Income Ratio |
-97.54
|
-11.51
|
-3.09
|
-12.11
|
-0.97
|
-0.63
|
-0.45
|
-1.09
|
-4.06
|
-1.34
|
Total Other Income/Expenses Net |
$770,000.00
|
$63,000.00
|
$591,000.00
|
$3.39 M
|
$426,000.00
|
$204,000.00
|
$166,000.00
|
$134,000.00
|
$114,000.00
|
$534,000.00
|
Income Before Tax |
-$39.47 M
|
-$20.91 M
|
-$23.88 M
|
-$16.25 M
|
-$12.96 M
|
-$8.97 M
|
-$9.24 M
|
-$16.49 M
|
-$31.24 M
|
-$22.90 M
|
Income Before Tax Ratio |
-97.71
|
-11.48
|
-3.02
|
-10.02
|
-0.94
|
-0.62
|
-0.44
|
-1.08
|
-4.05
|
-1.31
|
Income Tax Expense |
$69,000.00
|
$63,000.00
|
$2.69 M
|
$4.48 M
|
$426,000.00
|
$204,000.00
|
$166,000.00
|
$134,000.00
|
$114,000.00
|
$534,000.00
|
Net Income |
-$39.54 M
|
-$20.91 M
|
-$23.88 M
|
-$16.25 M
|
-$12.96 M
|
-$8.97 M
|
-$9.24 M
|
-$16.49 M
|
-$31.24 M
|
-$22.90 M
|
Net Income Ratio |
-97.88
|
-11.48
|
-3.02
|
-10.02
|
-0.94
|
-0.62
|
-0.44
|
-1.08
|
-4.05
|
-1.31
|
EPS |
-22.16 |
-38.39 |
-355.43 |
-234.41 |
-316.76 |
-282.12 |
-317.16 |
-585.11 |
-1133.13 |
-839.1 |
EPS Diluted |
-22.16 |
-38.39 |
-355.43 |
-234.41 |
-316.76 |
-282.12 |
-317.16 |
-585.11 |
-1133.13 |
-839.1 |
Weighted Average Shares Out |
$1.78 M
|
$544,759.00
|
$67,178.00
|
$69,339.00
|
$40,914.00
|
$31,806.00
|
$29,127.00
|
$28,186.00
|
$27,568.00
|
$27,290.00
|
Weighted Average Shares Out Diluted |
$1.78 M
|
$544,759.00
|
$67,178.00
|
$69,339.00
|
$40,914.00
|
$31,806.00
|
$29,127.00
|
$28,186.00
|
$27,568.00
|
$27,290.00
|
Link |
|
|
|
|
|
|
|
|
|
|